Abstract
Bronchial asthma can be simply defined as reversible airways obstruction occurring in people with airways hypersensitivity. Since a major component of this obstruction is bronchospasm, the primary goal of asthma therapy is relief and/or prevention of bronchospasm. During the earlier part of this century, the mainstay for relief from the bronchospasm of acute severe asthmatic attacks was the endogenous adrenergic agonist, epinephrine (parenterally administered); it is still quite widely used, by subcutaneous injection, to relieve acute asthma. However, since the 1940s, the synthetic agent isoproterenol (injected and inhaled) has served as an alternative adrenergic bronchodilator for both the acute and sustained treatment of asthma, and from the 1960s onward, the synthetic adrenergic agonists metaproterenol, albuterol (salbutamol), terbutaline, and others, given by the inhalation and oral routes, have also come into wide usage.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ahlquist, R. P.: A study of the adrenotropic receptors. Am.J. Physiol. 153: 586–600, 1948.
Armstrong, M. D., McMillan, A., and Shaw, K. N. F.: 3 Methoxy-4-hydroxy-D-mandelic acid, a urinary metabolite of norepinephrine. Biochim. Biophys. Ada 25:422,423,1957.
A very, G. S., ed.: Salbutamol: A review. Drugs 1:274–302, 1971.
Axelrod, J.: O-Methylation of epinephrine and other catechols in vitro and in vivo. Science 126:400,401,1957.
Barger, G. and Dale, H. H.: Chemical structure and sympathomimetic action of amines. J. Physiol. 41:19–59, 1910.
Bergman, J., Persson, H., and Wetterlin, K.: Two new groups of selective stimulants of adrenergic β-receptors. Experientia 25:899–901, 1969.
Berkow, R., ed.: The Merck Manual, 14th Ed., Merck Sharp & Dohme Research Laboratories, Rah way, NJ, 1982.
Brittain, R. T. and Harris, D. M.: Albuterol, in Pharmacological and Biochemical Properties of Drug Substances, vol. 1, M. E. Goldberg, ed., pp. 257–276, American Pharmaceutical Association Academy of Pharmaceutical Science, Washington, DC, 1977.
Brittain, R. T., Dean, C. M., and Jack, D.: Sympathomimetic bronchodi-lator drugs. Pharmacol. Ther. [B] 2:423–62, 1976.
Brittain, R. T., Farmer, J. B., Jack, D., Martin, L. E., and Simpson, W. T.: at-[Butylamino)methyl]-4-hydroxy-m-xylene-a’,a3-diol (AH. 3365): A selective β-adrenergic stimulant. Nature 219:862,863,1968.
Brittain, R. T., Jack, D., and Ritchie, A.C.: Recent β-adrenoreceptor stimulants, in Advance in Research, vol. 5, N. J. Harper and A. B. Simmonds, eds., pp. 197–253, Academic, London, 1970.
Bronsky, E., Bucholtz, G. A., Busse, W. W., Chervinsky, P., Condemi, J., Ghafouri, M. A., Hudson, L., Lakshminarayan, S., Lockey, R., Reese, M. E., Rennard, S. I., Segal, A., Smolley, L., Spector, S., Stablein, J. J., Van As, A., and Wilson, A.: Comparison of inhaled albuterol powder and aerosol in asthma. J. Allergy Clin. Immunol. 79:741–747, 1987.
Chervinsky, P.: Evaluation of a new selective beta-adrenergic receptor stimulant. Ann. Allergy 29:627–630, 1971.
Chervinsky, P.: Future drugs for the treatment of asthma, in Current Treatment of Ambulatory Asthma, G. A. Settipane, ed., pp. 120–122, New England and Regional Allergy Proceedings, Providence, 1986.
Choo-Kang, Y. F. J., Parker, S. S., and Grant, I. W. B.: Response of asthmatics to isoprenaline and salbutamol aerosols administered by intermittent positive-pressure ventilation. Br. Med. J. 4:465–468, 1970.
Choo-Kang, Y. F. J., Simpson, W. T., and Grant, I. W. B.: Controlled comparison of the bronchodilator effects of three β-adrenergic stimulant drugs administered by inhalation to patients with asthma. Br. Med. J. 2:287–289, 1969.
Chodosh, S.: Rational management of bronchial asthma. Arch. Intern. Med. 138:1394–1397, 1978.
Collin, D. T., Hartley, D., Jack, D., Lunts, L. H. C., Press, J. C., Ritchie A. C., and Toon, P.: Saligenin analogs of sympathomimetic catechola-mines. J. Med. Chem. 13:674–680, 1970.
Csáky, T. Z. and Barnes, B. A.: Cutting’s Handbookof Pharmacology, 7th Ed., Appleton-Century-Crofts, Norwalk, 1984.
Cullum, V. A., Farmer, J. B., Jack, D., and Levy, G. P.: Salbutamol: A new selective β-adrenoceptive receptor stimulant. Br.J.Pharmcol. 35: 141–151, 1969.
Dunlop, D. and Shanks, R. G.: Selective blockade of adrenoceptive beta receptors in the heart. Br. J. Pharmacol. Chemother. 32:201–218, 1968.
Dwyer, J. M.: Beta agonists in the management of asthma, in Current Treatment of Ambulatory Asthma, G. A. Settipane, ed., pp. 53–58, The New England and Regional Allergy Proceedings, Providence, 1986.
Engelhardt, A., Hoefke, W., and Wick, H.: Pharmakologie des Sympatho-mimeticums l-(3,5-Dihydroxyphenyl)-l-hydroxy-2-isopropylamino-äthan. Arzneimittelforsch. 11: 521–525, 1961. (Read in translation in Drugs Made in Germany 4:123-131,1961.)
Gebbie, T.: Therapeutic choices in asthma, in Steroids in Asthma: A Re-appraisal in the Light of Inhalation Therapy, T. J. H. Clark, ed., pp. 83–102, Adis, Auckland, 1983.
Hartley, D., Jack, D., Lunts, L. H. C., and Ritchie, A. C: New class of selective stimulants of beta-adrenergic receptors. Nature 219:861,862, 1968.
Himori, N. and Taira, N.: Assessment of the selectivity of OPC-2009, a new β2-adrenoceptor stimulant, by the use of the blood-perfused trachea in situ and of the isolated blood-perfused papillary muscle of the dog. Br. J. Pharmacol. 61:9–17, 1977.
Iafrate, R. P., Massey, K. L., and Hendeles, L.: Current concepts in clinical therapeutics: Asthma. Clin. Pharm. 5:206–227, 1986.
Jack, D.: Recent β-adrenoreceptor stimulants and the nature of β-adreno-receptors. Pharm. J. 205:237–240, 1970.
Joad, J. P., Ahrens, R. C., Lindgren, S. D., and Weinberger, M. M.: Relative efficacy of maintenance therapy with theophylline, inhaled albuterol, and the combination for chronic asthma. J. Allergy Clin. Immunol. 79: 78–85, 1987.
Kass, I. and Mingo, T.S.: Bitolterol mesylate (WIN32784)aerosol: Anew long-acting bronchodilator with reduced chronotropic effects. Chest 78:283–287, 1980.
Kelman, G. R., Palmer, K. N. V., and Cross, M. R.: Cardiovascular effects of AH. 3365 (Salbutamol). Nature 221:1251, 1969.
Konzett, H.: Neue broncholytische hochwirksame Körper der adrenalinreihe. Arch. Exp. Path. Pharmak. 197:27–40, 1940a.
Konzett, H.: Zur Pharmakolgie neuer adrenalinverwandter Körper. Arch. Exp. Path. Pharmak. 197:41–56, 1940b.
Lampe, K., ed. Drug Evaluations, 6th Ed., American Medical Association, Chicago, 1986.
Lands, A. M. and Brown, T. G., Jr.: A comparison of the cardiac stimulating and bronchodilator actions of selected sympathomimetic amines. Proc. Soc. Exp. Biol. Med. 116:331–333, 1964.
Lands, A. M. and Howard, J. W.: A comparative study of the effects of 1-arterenol, epinephrine and isopropylarterenol on the heart. J. Pharmacol. Exper. Ther. 106:65–76, 1952.
Lands, A. M., Groblewski, G. E., and Brown, T. G., Jr.: Comparison of the action of isoproterenol and several related compounds on blood pressure, heart and bronchioles. Arch. Pharmacodyn. Ther. 161:68–75, 1966.
Lands, A. M., Arnold, A., McAuliff, J. P., Luduena, F. P., and Brown, T. G., Jr.: Differentiation of receptor systems activated by sympathomimetic amines. Nature 214:597,598, 1967a.
Lands, A. M., Luduena, F. P., and Buzzo, H. J.: Differentiation of receptors responsive to isoproterenol. Life Sci. 6:2241–2249, 1967b.
Lands, A. M., Luduena, F. P., Grant, J. I., and E. Ananenko: The pharma-cologic action of some analogs of l-(3,4-dihydroxyphenyl)-2-amino-l-butanol (ethylnorepinephrine). J. Pharm. Exp. Ther. 99:45–56, 1950.
Leif er, K. N. and Wittig, HJ.: The beta-2 sympa thomimetic aerosols in the treatment of asthma. Ann. Allergy 35:69–80, 1975.
Levy, B.: Dimethyl isopropylmethoxamine: A selective beta-receptor blocking agent. Br. J. Pharmacol. Chemother. 27:277–285, 1966.
Lewis, A. A. G., ed.: Salbutamol. Postgrad. Med. J. 47 (Suppl.): 1971.
Minatoya, H.: Studies on bitolterol, di-p-toluate ester of N-tert-butylar-terenol: A new long-acting bronchodilator with reduced cardiovascular effects. J. Pharmacol. Exp. Ther. 206:515–527, 1978.
O’Donnell, S. R.: A selective ß-adrenoreceptor stimulant (TH1165a) related to orciprenaline. Eur. J. Pharmacol. 12:35–43, 1970.
Palmer, K. N. V. and Diament, M. L.: Effect of salbutamol on spirometry and blood-gas tensions in bronchial asthma. Br. Med. J. 1:31,32,1969.
Prime, F.J.: Adrenergic receptors, bronchodilators and asthma. Drugs 1: 269–273, 1971.
Riding, W. D., Chatterjee, S. S., and Dinda, P.: Clinical trial of a new beta-adrenergic stimulant in asthma. Br. J. Clin. Prac. 23:217–219, 1969.
Ross, S.B.: In vivoinactivation of catecholamines in mice. Acta Pharmacol, et Toxicol. 20:267–273, 1963.
Shanks, R. G.: The discovery of beta-adrenoceptor blocking agents. Trends Pharm. Sci. 5:405–409, 1984.
Sheller, J. R. and Snapper, J. R.: Asthma in adults and adolescents, in Conn’s Current Therapy, R. E. Rakel, ed., pp. 600–604, W. B. Saunders, Philadelphia, 1987.
Tashkin, D. P. and Jenne, J. W.: Alpha and beta adrenergic agents, in Bronchial Asthma: Mechanisms and Therapeutics, 2nd Ed., E. B. Weiss, M. S. Segal, and M. Stein, eds., pp. 604–639, Little Brown, Boston, 1985.
Tattersfield, A. E. and Mc Nicol, M.W.: Salbutamol and isoproterenol: A double-blind trial to compare bronchodilator and cardiovascular activity. N. Engl. J. Med. 281:1323–1326, 1969.
Taylor, D. R., Buick, B., Kinney, C., Lowry, R. C., and McDevitt, D. G.: The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction. Am. Rev. Respir. Dis. 131:747–751, 1985.
Warrell, D. A., Robertson, D. G., Newton Howes, J., Conolly, M. E., Paterson, J. W. Beilin, L. J., and Dollery, C. T.: Comparison of cardio-respiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. Br. Med. J. 1:65–70, 1970.
Weinstein, A. M.: Asthma, McGraw-Hill, New York, 1987.
Williams, M. H.: Inhaled versus oral bronchodilators, in Current Treatment of Ambulatory Asthma, E. A. Settipane, ed., pp. 75–77, New England and Regional Allergy Proceedings, Providence, 1986.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media New York
About this chapter
Cite this chapter
Maxwell, R.A., Eckhardt, S.B. (1990). Albuterol. In: Drug Discovery. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-0469-5_25
Download citation
DOI: https://doi.org/10.1007/978-1-4612-0469-5_25
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4612-6775-1
Online ISBN: 978-1-4612-0469-5
eBook Packages: Springer Book Archive